Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS · Delayed Price · Currency is USD
0.0180
-0.0020 (-10.00%)
At close: Oct 15, 2026
Oncotelic Therapeutics Market Cap
Oncotelic Therapeutics has a market cap or net worth of $8.24 million as of October 15, 2026. It is the 42,601st most valuable company in the world and the 5,727th biggest in the United States. Its market cap has decreased by 80.46% in one year.
Market Cap
8.24M
Enterprise Value
20.82M
Revenue
250.00K
Global Rank
Country Rank
#5,727 United States
PE Ratio
0.03
ChartMarket Cap Chart
Since April 23, 2019, Oncotelic Therapeutics's market cap has decreased from 9.14M to 8.24M, a decrease of -9.93%. That is a compound annual growth rate of -1.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 8.24M | -77.82% |
| Dec 31, 2025 | 37.13M | 160.46% |
| Dec 31, 2024 | 14.26M | -6.64% |
| Dec 29, 2023 | 15.27M | -13.24% |
| Dec 30, 2022 | 17.60M | -71.94% |
| Dec 31, 2021 | 62.72M | 225.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| America Great Health | 12.69M |
| EOM Pharmaceuticals Holdings | 12.02M |
| Brainstorm Cell Therapeutics | 9.40M |
| Zeo ScientifiX | 8.98M |
| Adaptimmune Therapeutics | 7.55M |
| TRON Group | 6.99M |
| Curative Biotechnology | 6.79M |
| OSR Health | 6.65M |